Financhill
Back

Catalyst Pharmaceuticals Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
57

CPRX
Catalyst Pharmaceuticals

Last Price:
21.95
Seasonality Move:
-2.02%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Catalyst Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 31.9% based on the past 17 years of stock performance.
  • Catalyst Pharmaceuticals has risen higher in 11 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%
  • Is Catalyst Pharmaceuticals Stock Undervalued?
    The current Catalyst Pharmaceuticals [CPRX] share price is $21.96. The Score for CPRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Catalyst Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 31.9% based on the past 17 years of stock performance.

Catalyst Pharmaceuticals Stock Rating

Buy
57
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals overpriced?

  • Catalyst Pharmaceuticals has risen higher in 11 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.71%

Catalyst Pharmaceuticals Stock Price History

Is CPRX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com

52-Week Data

52-Week High:
22.27
52-Week Low:
12.27

Prediction Charts

Market Cap:
2.61B
Price in USD:
21.96
Volume:
872.46K
Beta:
1.10

Technical Analysis

SMA50:
20.55
SMA100:
18.78
SMA200:
17.06
52-Wk Change:
66.87%

Stock Predictions

  • Is Catalyst Pharmaceuticals stock public?
    Yes, Catalyst Pharmaceuticals is a publicly traded company.
  • What is the Catalyst Pharmaceuticals stock quote today?
    The Catalyst Pharmaceuticals stock price is 21.96 USD today.
  • How to buy Catalyst Pharmaceuticals stock online?
    You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 21.20 21.67 21.85 21.02
Oct-18 21.17 21.24 21.49 21.12
Oct-21 21.35 21.02 21.38 20.87
Oct-22 20.88 21.46 21.48 20.81
Oct-23 21.46 21.34 21.62 21.02
Oct-24 21.37 21.41 21.62 21.11
Oct-25 21.50 21.46 21.93 21.42
Oct-28 21.76 21.87 22.20 21.67
Oct-29 21.77 21.77 22.20 21.56
Oct-30 21.72 21.59 21.91 21.49
Oct-31 21.42 21.80 21.95 21.20
Nov-1 21.77 21.89 22.27 21.68
Nov-4 21.82 21.74 21.96 21.30
Nov-5 21.57 21.96 22.05 21.41

Catalyst Pharmaceuticals Earnings

Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Catalyst Pharmaceuticals Forecast Revenue Growth

Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.